Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, David J, Tan, Gene S, Palese, Peter, Ravetch, Jeffrey V·2014·Nature Medicine
DOI 10.1038/nm.3443

Cited by (763)

Items 701–763 of 763

  1. Vaccination with B.1.1.7, B.1.351 and P.1 variants protects mice from challenge with wild type SARS-CoV-2
    Fatima Amanat, Shirin Strohmeier, Philip S. Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, Vladimir I. Vigdorovich, D. Noah Sather, Lynda Coughlan, Florian Krammer · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses
    Syed Mohammad Moin, Jeffrey C. Boyington, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie, Gabriele Cerutti, Crystal Sao‐Fong Cheung, Alberto Cagigi, John R. Gallagher, Joshua Brand, Madhu S. Prabhakaran et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
    Arman Izadi, Magdalena Godzwon, Mats Ohlin, Pontus Nordenfelt · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availability
    Mirte N. Pascha, Marlies Ballegeer, Rien van Haperen, Annick C. Kooij, Danique M. van Miltenburg, Anthony A. Smits, Jelle G. Schipper, Hongrui Cui, Irina C. Albulescu, Berend‐Jan Bosch et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Cross-protection Mechanisms of Influenza Virus Vaccines
    Yu-Jin Kim · 2022 · Digital Archive @ GSU
  6. Late Antigen Regulates the Differentiation of Cytotoxic CD4 T Cells in Influenza Infection
    Allen M. Vong · 2017 · eScholarship@UMassChan
  7. Immune mechanisms that determine the quality of antibody responses to vaccines
    Gustaf Lindgren · 2019 · Figshare
  8. Phenotypic heterogeneity in particle size is a viral mechanism of persistence
    Tian Li, Zhenyu Li, Erin E. Deans, Eva Mittler, Meisui Liu, Kartik Chandran, Tijana Ivanovic · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Serum-Saving Systems Serology Screen for Functional Antibody Profiling
    Audrey L. Butler · 2018 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  10. The Zika virus NS1 protein as a vaccine target
    Mark J. Bailey, Gene S. Tan · 2021 · Elsevier eBooks
  11. Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development
    Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, Zia Ur Rahman, Zainab Fatima · 2021 · Exploration of Immunology
  12. Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
    Jose L. Garrido, Matías A. Medina, Felipe Bravo, S. McGee, F. Fuentes, M. Calvo, James Bowman, C. Bahl, M. I. Barria, R. A. Brachman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Broadly-neutralizing antibodies that bind to the influenza hemagglutinin stalk domain enhance the effectiveness of neuraminidase inhibitors via Fc-mediated effector functions
    Ali Zhang, Hanu Chaudhari, Yonathan Agung, Michael R. D’Agostino, Jann Catherine Ang, Matthew S. Miller · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  14. A Low-Dose Triple Antibody Cocktail Against the Ectodomain of the Matrix Protein 2 of Influenza A Is A Universally Effective and Viral Escape Mutant Resistant Therapeutic Agent
    Teha Kim, Lynn H. Bimler, Sydney L. Ronzulli, Amber Y. Song, Scott K. Johnson, Cheryl A. Jones, Stephen Mark Tompkins, Silke Paust · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Faculty Opinions recommendation of Rationally designed TLR4 ligands for vaccine adjuvant discovery.
    Jerrold P Weiss · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  16. Omicron Variant Could be an Antigenic Shift of SARS-CoV-2
    Anju Kaushal · 2023 · Qeios
  17. The lipid Gb3 promotes germinal center B cell responses and anti-viral immunity
    Pankaj Sharma, Xiaolong Zhang, Kevin Ly, Yuxiang Zhang, Yu Hu, Adam Yongxin Ye, Jianqiao Hu, Ji Hyung Kim, Mumeng Lou, Chong Wang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Omicron Variant Could be an Antigenic Shift of SARS-CoV-2
    Anju Kaushal · 2023 · Qeios
  19. Human cross-protective antibodies to occluded epitopes in influenza hemagglutinin antigen
    Yu Adachi, Keisuke Tonouchi, Yoshimasa Takahashi · 2019 · Uirusu
  20. Protective antibodies against influenza virus neuraminidase
    Seiya Yamayoshi, Atsuhiro Yasuhara · 2019 · Uirusu
  21. Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses
    Chia-Ying Wu, Yung-Chieh Tseng, Shao-En Kao, Liyang Wu, Jen-Tzu Hou, Yu‐Chih Yang, Pei‐Wen Hsiao, Juine-Ruey Chen · 2023 · Antiviral Research
  22. A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
    Min You, Fentian Chen, Chao Yu, Yuanzhi Chen, Yue Wang, Xue Liu, Xueran Guo, Bing Nan Zhou, Xin Wang, Boya Zhang et al. · 2023 · Frontiers in Pharmacology
  23. Antigen specificity shapes antibody functions in tuberculosis
    Joshua Miles, Pei Lu, Shuangyi Bai, Génesis P. Aguillón-Durán, Javier E. Rodríguez-Herrera, Bronwyn M. Gunn, Blanca I. Restrepo, Lenette L. Lu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  24. ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2
    Jenna K. Dick, Dustin M. Hicks, Venkatramana Divana Krishna, Jules A. Sangala, Benjamin T. Zandstra, Carly Baehr, J. Sjef Verbeek, Mark Steven Cragg, Maxim C.‐J. Cheeran, Marco Pravetoni et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Cross Protection and Sustained Immunity Against Influenza a Viruses in Mice Provided by Core-Shell Structured Lipopolyplex Delivered mRNA Vaccine with Optimized Sequences Coding HAstem-Na-Fused Antigens
    Tangqi Wang, Ruiwen Han, Zhanyihao Hao, Xueting Cheng, Jia Li, Chengcheng Zhai, Donghong Wang, Yao Liang Deng, Liang Zhang, Wenjie Tan · 2025 · SSRN Electronic Journal
  26. Fc Receptors and Fc Receptor-Like Molecules
    Marc Daëron · 2024 · Elsevier eBooks
  27. Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity
    Junsuke Nohara, Tyler D. Evangelous, Madison Berry, Whitney Edwards Beck, Sarah V. Mudrak, Shalini Jha, Roger Keith Reeves, Kevin J. Wiehe, Justin Pollara, Georgia D. Tomaras et al. · 2025 · Pathogens and Immunity
  28. SMALL MOLECULES WHICH CAN KEEP THE ECTODOMAINS OF HUMAN FcγRIIIa “CLOSED”: THERAPY FOR AUTOIMMUNE THROMBOCYTOPENIA PURPURA?
    Fnu Ashish · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  29. Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation
    Xueyong Zhu, Ahmed Magdy Khalil, Michael S. Piepenbrink, Wenli Yu, Yao Ma, Luis Martínez‐Sobrido, Ian A. Wilson, James J. Kobie · 2025 · Communications Biology
  30. Antibodies, Memory B Cells, and Antigen Valency Reshape B Cell Responses to Drifted Influenza Virus Vaccination
    Laura Reusch, Nimitha R. Mathew, Karin Schön, Ivan Košík, James S. Gibbs, Madeleine C. Mankowski, Danica F. Besavilla, Jonathan Wilson Yewdell, Mats Bemark, Davide Angeletti · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  31. DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection
    Ane Marie Anderson, Elias Tjärnhage, Daniëla Maria Hinke, Ranveig Braathen, Gunnveig Grødeland, Bjarne Bogen · 2025 · Molecular Therapy — Nucleic Acids
  32. Protective activity of CR9114 universal antibody isotypes against influenza A virus in vivo
    Ekaterina Romanovskaya-Romanko, Marina A. Plotnikova, Veronika A. Oleynik, Aram A. Shaldzhyan, Varvara S. Monakhova, Балабашин Дмитрий Сергеевич, Victoria A. Toporova, Teimur K. Aliev, Sergey A. Klotchenko · 2025 · Journal of microbiology epidemiology immunobiology
  33. Intranasal Vaccine Induces Broad and Long-Lasting Immunity Against the Hemagglutinin Stem of Group 2 Influenza a Viruses
    Abenaya Muralidharan, Jérémie Prévost, Angela M Sloan, Levi A. Tamming, Annabelle Pfeifle, Caroline Gravel, Sathya N. Thulasi Raman, Gary Van Domselaar, Michael Johnston, Lisheng Wang et al. · 2025 · SSRN Electronic Journal
  34. Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus
    Lei Deng, Jiaye Liu, Yu Peng · 2026 · Virologica Sinica
  35. Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammation
    Samantha Mackin, Chieh-Yu Liang, Courtney E. Karl, Maksim Kleverov, Mehak Zahoor Khan, Thendral Selvam, Matthias Mack, Galit Alter, Barbara Guarino, Davide Corti et al. · 2026 · mBio
  36. Preexisting IgG forms immune complexes and links local thermal reactogenicity with immunogenicity in influenza vaccination
    Julia R. Hirsiger, Silke Scarascia, Mike Recher, Glenn R. Bantug, Christoph T. Berger · 2026 · npj Vaccines
  37. Pre-existing systemic and nasal antibodies against avian H5 influenza A viruses vary according to childhood imprinting
    Peta Edler, Kevin John Selva, Ellie Reilly, Malet Aban, Ian Barr, Jennifer A. Juno, Adam K. Wheatley, Amy W. Chung, Stephen John Kent, David J. Price et al. · 2026 · mBio
  38. Pre-existing systemic and nasal antibodies against avian H5 influenza A viruses vary according to childhood imprinting
    Peta Edler, Kevin John Selva, Ellie Reilly, Malet Aban, Ian Barr, Jennifer A. Juno, Adam K. Wheatley, Amy W. Chung, Stephen John Kent, David J. Price et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Structure and functional diversity of antibodies targeting the P. falciparum circumsporozoite protein C-terminal domain
    Re’em Moskovitz, Iszac Burton, Nathan Beutler, Gonzalo Ernesto González-Páez, Thea R. Zalunardo, Michael Bick, Justin Ndihokubwayo, Kiara Gambuzza, Jerry Zhao, Robyn L. Stanfield et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
    Iván Sanz-Muñoz, Carlos J. Ciria-Gil, Alejandro Martín-Toribio, Marina Toquero-Asensio, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Marta Hernández, Iris Barragan-Martin, Sara Landeras-Bueno, José María Eiros et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Antibodies to influenza A virus hemagglutinin and neuraminidase limit egress and alter the physical properties of released virus particles
    Anna Jaeggi-Wong, Antonio Santos‐Peral, Edward A. Partlow, Tongyu Liu, Tijana Ivanovic · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Site-Specific Analysis of Bone Morphogenetic Protein Receptor Type 2 N -Glycosylation Reveals High Heterogeneity at Site Involved in Ligand Binding
    Valeria Nazaire, Alejandro Garcia, Carlos Humberto Paván, Kevin Brown Chandler · 2026 · ACS Omega
  43. Optimizing an avian influenza vaccine using a novel Bacterial Enzymatic Combinatorial Chemistry (BECC) TLR4 adjuvant
    Devon V Riley, Lauren Baracco, Sayan Das, Brandon M Tenaglia, Sydney Speed, Carly Dillen, Juliahna Hayes, Samanta Del Veliz, Haye Nijhuis, Valerie Le Sage et al. · 2026 · mSphere
  44. Germinal center-independent memory B cells provide rapid protection from lethal influenza challenges
    Elif Çakan, Faez Amokrane Nait Mohamed, Anson Hui, Essi C. Logan, Nicole Ingram, Caroline A Alexander, Jack Smerczynski, Chinmay V. Gadiraju, Emma Barnes, DANIEL A. MOUNIER et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Elicitation of stem-directed antibodies in rhesus macaques by a conventional hemagglutinin immunogen
    Shuqin Gu, Joel Finney, Kan Luo, Sarah M. Valencia, Dieter Mielke, Tarra A. Von Holle, DJ Marshall, Robert Parks, Laura L. Sutherland, Richard M. Scearce et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine
    Wen-Chien Wang, Marwa Alhashimi, Vivek Gairola, Muralimanohara S. T. Murala, Shaurya Dumka, Ekramy E. Sayedahmed, Suryaprakash R. Sambhara, Suresh K. Mittal · 2026 · Vaccine
  47. An In Vitro Screen Identifies H1 Influenza Hemagglutinin Substitutions That Alter mRNA-LNP Vaccine Responses Against the Stalk Domain
    Samuel W. Rovito, Po-Ling Chen, Guohua Yang, Haley N Writt, Ashley N. Zalla, Marissa A. Donofrio, Jonathan N. Fogo, Richard J. Webby, James D. Brien, Charles J. Russell · 2026 · Vaccines
  48. A bispecific antibody targeting conserved hemagglutinin epitopes confers broad protection against H7 avian influenza and accelerates viral clearance via localized respiratory delivery
    Han Wu, Fan Yang, Ping Wang, Jiamin Fu, Jun Zhang, Jing Guo, 程林芳, Fumin Liu, 吴南屏, Hangping Yao et al. · 2026 · Emerging Microbes & Infections
  49. Characterisation of a human monoclonal antibody targeting a conserved epitope at the base of the HA head of influenza A(H3N2) virus
    Seiya Yamayoshi, Taiki Hamabata, Yuka Inoue, Maki Kiso, Moe Okuda, Hiroaki Akasaka, Wataru Shihoya, Takeaki Imamura, Yukimasa Matsuzawa, Daisuke Jubishi et al. · 2026 · EBioMedicine
  50. ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2.
    Jenna K. Dick, V. Krishna, D. Hicks, Jules A. Sangala, Robert J. Oldham, Benjamin T. Zandstra, C. Baehr, J. Verbeek, M. Cragg, M. Pravetoni et al. · 2026 · Journal of Immunology
  51. Memory B Cell Repertoire of a Repeatedly Vaccinated Individual Includes Influenza Hemagglutinin-Specific Cross-Group Binders with Affinity Beyond A(H1N1)pdm09 and A(H3N2) Seasonal Strains
    Margarita Mishina, Christopher M. Horn, Zachary S. Ende, Vasiliy Mishin, Crystal Holiday, Sujatha Seenu, Jason R. Wilson, Weiping Cao, Mili Sheth, Dhwani Govil Batra et al. · 2026 · Vaccines
  52. Vaccination of newborn monkeys with an influenza HA stem nanoparticle adjuvanted with R848 and AddaVax results in broadened HA recognition and increased antibody secreting cells to HA stem following H1N1 challenge
    Kali F. Crofts, Beth C. Holbrook, Colby J. Hendrix, Ava C. DiPaolo, Courtney L Page, Rebecca A. Gillespie, Heather A. Burkart, Masaru Kanekiyo, Martha A. Alexander‐Miller · 2026 · Frontiers in Immunology
  53. Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus
    Yiqing Zheng, Bingchen Qiao, Zihe Gao, Xinyi Zhang, Ni Zhao, Xiaofei Song, Jihui Ping, Juan Su · 2026 · Vaccine
  54. Elicitation of Potent H5N1- and H7N9-Neutralizing Antibody Responses in Rhesus Macaques by Sequential Heterologous Vaccination with mRNA and Adenoviral Vectors Encoding Full-Length Hemagglutinins
    Brandon C. Rosen, Jack T. Mauter, Thomas B. Voigt, Giovana de Figueiredo Godoy, Elizabeth K.-Y. Walker, Johan J. Louw, Noor Ghosh, Christakis Panayiotou, Aaron Yrizarry-Medina, Joshua Terao et al. · 2026 · Viruses
  55. Monoclonal antibodies raised against the Junín virus glycoprotein show broad reactivity and provide protection in vivo
    Garazi Peña Alzua, Sharon Jan, Fatima Amanat, Grecia Sandoval, Christopher A. Sumner, Stephen Won, Anna L. Lara, Anupama Sinha, Brooke Harmon, Elizabeth B. Allmon et al. · 2026 · mBio
  56. Pre-existing cross-subtype serological responses against H5Nx in health care workers
    Katrina Dionne, Étienne Bélanger, Mehdi Benlarbi, Guillaume Beaudoin-Bussières, Claudia Santos Saenz, Shilei Ding, Catherine Bourassa, Halima Medjahed, Morgan Jennings, Geneviève Laroche et al. · 2026 · Journal of Virology
  57. Phenuivirus glycoprotein Gc domain is a conserved target of cross-functional monoclonal antibodies
    Denise Guerra, Edoardo Cherubini, Mabel RM Echague, Giuseppe Maccari, Gabriele Anichini, Caterina Valoti, Arianna Nurrito, Sandra O Zelech, Emma C. Ryan, Nicole V. Johnson et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Polyclonal breast milk–derived secretory IgA confers broad antiviral protection against multiple respiratory viruses
    Yona Tugg, Jann Catherine Ang, Imran Ahmed, Rikin Mehta, Viraj P. Mane, Sam Afkhami, Matthew S. Miller · 2026 · Science Advances
  59. Towards influenza vaccine universality: Smart vaccine regimens and adjuvant-driven germinal center responses
    Arini Arsana, Wandi Zhu, Sang‐Moo Kang, Bao‐Zhong Wang · 2026 · Virology
  60. Pooled intravenous immunoglobulins exhibit broad binding and Fc-mediated activity against diverse SARS-CoV-2 variants
    Sinem Ulusan, Alena J. Markmann, Usaphea P. Vanna, Izabella Castillo, Edwing Cuadra, Melissa Mattocks, Joshua A. Ekanem, William Tart, Jason R. Mock, Ralph Steven Baric et al. · 2026 · Journal of Virology
  61. Mice with diverse microbial exposure histories
    Ryan Langlois · 2025 · ImmPort
  62. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgR-dependent protection in vivo
    Jeffrey Ravetch · 2024 · ImmPort
  63. Long-lasting B cell convergence to broadly reactive epitopes after chimeric HA vaccination
    Patrick Wilson · 2025 · ImmPort